Brain Fog: The 7 Things Your Blood Tests Might Be Missing

Walking into a room and forgetting why. Losing the thread mid-sentence. Reading the same paragraph three times. Feeling slower than you were previously, then being told that your blood tests are normal.

Brain fog describes a cluster of cognitive symptoms rather than a single diagnosis.

Brain fog is not a diagnosis. It is a colloquial, non-medical term describing difficulties with attention, memory, concentration, word-finding, planning, multitasking and mental energy. It is a transdiagnostic symptom cluster reported in perimenopause, thyroid disease, iron deficiency, vitamin B12 deficiency, insulin resistance, sleep disorders, long COVID, mood disorders and following chemotherapy.[1][2][3]

That breadth is precisely why the investigation must be systematic. A standard panel can exclude some serious conditions while failing to explain why you feel cognitively slowed.

1. Ferritin and iron status

Iron deficiency can affect cognition before anaemia develops. A normal haemoglobin result does not confirm adequate iron availability for the brain, muscles or neurotransmitter pathways.

Ferritin below approximately 30 µg/L is commonly interpreted as depleted iron stores in an appropriate clinical context. Inflammation can raise ferritin and obscure deficiency, making transferrin saturation and inflammatory markers relevant.[4]

Marker	Conventional interpretation	Why context matters	A more informative approach
Ferritin	Iron stores appear adequate if within the laboratory range	Laboratory reference ranges may include levels associated with symptoms; inflammation can falsely elevate ferritin	Interpret with full blood count, transferrin saturation and CRP. Review menstrual loss, diet and gastrointestinal symptoms
Haemoglobin	Anaemia is absent if normal	Iron deficiency without anaemia can still contribute to fatigue, poor concentration and cognitive slowing	Do not use haemoglobin alone to assess iron status

Read the detailed guide to iron deficiency without anaemia and ferritin.

2. Active B12, folate and homocysteine

Total serum B12 can appear normal or high despite impaired cellular availability. This is particularly relevant following supplementation, with altered binding proteins, or where absorption is compromised.

Methylmalonic acid (MMA) and homocysteine can provide additional information when symptoms are significant but serum B12 is not clearly deficient. MMA is more specific to B12 status, although renal impairment can affect interpretation. Homocysteine may rise with B12, folate or vitamin B6 deficiency and is not specific to one nutrient.[5]

Marker	Conventional interpretation	Why context matters	A more informative approach
Total serum B12	B12 deficiency is unlikely if the result is in range	Serum concentration does not always reflect tissue-level function	Consider active B12 with MMA and homocysteine when symptoms or risk factors persist
Folate	Folate status is adequate if serum folate is normal	Folate and B12 deficiency can overlap and both affect one-carbon metabolism	Interpret with B12, homocysteine, diet and absorption history
Homocysteine	Raised homocysteine is non-specific	It may reflect B12, folate or B6 deficiency, renal impairment and other factors	Use as part of a marker pattern rather than in isolation
MMA	Raised MMA suggests cellular B12 deficiency	Renal function and some analytical factors influence the result	Interpret alongside B12, active B12 and renal markers

See the companion articles on the active B12 test and cellular deficiency and homocysteine and brain fog.

3. A full thyroid assessment, not TSH alone

TSH is an important first-line thyroid marker. It does not, however, describe every aspect of thyroid physiology or autoimmune activity.

Depending on the clinical picture, a fuller assessment may include free T4, free T3, thyroid peroxidase antibodies and thyroglobulin antibodies. Iron status also interacts with thyroid hormone production and metabolism. Low iron stores can therefore complicate the interpretation of fatigue, cold intolerance and cognitive slowing.[6]

Marker	Conventional interpretation	Why context matters	A more informative approach
TSH	Primary screening marker for thyroid dysfunction	A single result may not explain symptoms, treatment effects or autoimmune activity	Interpret with free T4 and the clinical picture
Free T4 and free T3	Circulating thyroid hormones	Results may be affected by illness, medication, nutritional status and assay variation	Review alongside TSH, symptoms and iron status
TPO and thyroglobulin antibodies	Evidence of thyroid autoimmunity	Antibodies can be present before overt thyroid dysfunction	Consider where autoimmune thyroid disease is suspected

Thyroid testing sidebar: reverse T3
Reverse T3 (rT3) is an inactive metabolite of thyroid hormone. The claim that rT3 blocks thyroid hormone receptors is not supported by adequate evidence. rT3 testing is not recommended as a routine thyroid assessment by professional guidance, including the American Thyroid Association. It should not replace evidence-based thyroid evaluation.[7]

Read why TSH alone may not be enough.

4. Fasting insulin and HOMA-IR

Glucose and HbA1c can remain within range while insulin resistance is developing. Higher insulin requirements and substantial post-meal glucose variation may affect energy, attention and perceived mental clarity before conventional glucose markers change.

Fasting insulin, interpreted with fasting glucose, can be used to calculate HOMA-IR. This is not a standalone diagnosis. It is a context-dependent estimate of insulin resistance that must be considered alongside waist circumference, blood pressure, lipids, PCOS, family history and medication.[8]

See the guide to fasting insulin and HOMA-IR.

5. Vitamin D

Vitamin D thresholds are primarily established around bone health. They do not necessarily define the concentration associated with optimal energy, immune or neurological function.

Low vitamin D may coexist with fatigue, musculoskeletal symptoms and reduced wellbeing. The result should be interpreted with season, sun exposure, skin pigmentation, body composition, diet and clinical history. Supplementation should be appropriate to the result rather than added indiscriminately.[3][9]

6. Magnesium and other micronutrients

Most magnesium is stored in bone and tissue. Serum magnesium represents only a small extracellular compartment and is tightly regulated. A normal serum result therefore does not always exclude suboptimal total-body status, although this does not justify diagnosing deficiency from symptoms alone.[10]

Marker	Conventional interpretation	Why context matters	A more informative approach
Serum magnesium	Magnesium status is adequate if serum magnesium is normal	Serum magnesium may remain normal despite depleted tissue stores	Interpret with diet, gastrointestinal health, kidney function, medication and symptoms
Zinc, copper and selected micronutrients	Not usually included in a standard panel	Restrictive diets, malabsorption and chronic gastrointestinal disease can alter status	Test selectively when the history creates a clinical question
CRP and related inflammatory markers	Inflammation is absent if CRP is normal	Some inflammatory processes fluctuate or are not captured by one test	Repeat or broaden assessment only when the clinical picture warrants it

Read the companion article on what a normal serum magnesium result may miss.

7. Sex hormones and the perimenopause

More than two-thirds of women report cognitive symptoms such as forgetfulness, word-finding difficulty or reduced concentration during the menopause transition.[11] The experience is real, although routine hormone blood tests do not always identify the cause because oestrogen and progesterone fluctuate substantially during perimenopause.

Oestrogen is not solely a reproductive hormone. It influences brain networks involved in attention, memory, mood, sleep and thermoregulation. Falling or fluctuating oestrogen can coincide with hot flushes, night sweats, sleep fragmentation, anxiety and changes in cognitive confidence.[11][12]

The cortisol awakening response is also relevant to sleep and stress physiology. It is not a universal screening test for brain fog, but disrupted sleep timing, prolonged stress and altered morning alertness can materially influence cognition.

Marker	Conventional interpretation	Why context matters	A more informative approach
Oestradiol, FSH and LH	Used to assess reproductive hormone status	Perimenopausal levels fluctuate and a single sample may be misleading	Prioritise symptom pattern, cycle history, age and clinical assessment
SHBG and testosterone	Often associated mainly with libido	Testosterone has roles in energy, muscle, mood, cognition and bone health in women, not libido alone	Interpret with symptoms, SHBG and the wider hormonal picture
Cortisol	A single cortisol result is often over-interpreted	Cortisol follows a circadian rhythm and is affected by sleep, illness and medication	Assess sleep timing, stress physiology and clinical context before considering specialised testing

Read about hormone blood tests and SHBG, oestrogen, menopause and the brain-body connection, and the cortisol awakening response.

Brain fog can be subjective and still clinically important

A 2025 systematic review and meta-analysis of 24 studies involving 5,629 participants found that the overall association between subjective cognitive complaints and objective cognitive performance during menopause was not statistically significant. A small association was identified specifically for learning efficiency.[13]

This does not invalidate the symptom. It means that self-reported cognitive difficulty and performance on formal neuropsychological tests measure related but different experiences. Sleep disruption, vasomotor symptoms, mood, stress and hormonal change may affect how a person functions day to day without producing a clear abnormality on a brief test.[11][12]

Being told that your tests are normal is not the same as being told that nothing is wrong.

Brain fog is a real experience, even when standard blood tests do not explain it.

Long COVID and chemotherapy-related cognitive symptoms

Brain fog is reported in approximately 20–30% of people with long COVID, with estimates varying according to the population and definition used. Proposed mechanisms include neuroinflammation, immune dysregulation, microvascular injury, metabolic dysfunction and disruption of the gut-brain axis.[2][3]

A 2025 transdiagnostic review argues that brain fog is a genuine and measurable clinical phenomenon, but one that lacks a standardised definition.[1] Similar cognitive symptoms occur following chemotherapy. A systematic review in breast cancer survivors found self-reported cognitive impairment in approximately 44%, while objective impairment varied by assessment method and was generally lower.[14]

These figures demonstrate why symptoms should be assessed rather than dismissed. They do not identify one universal treatment.

What standard panels commonly miss

When routine results do not explain the presentation, clinicians should also consider:

Sleep apnoea, insomnia and fragmented sleep.
Mood and anxiety disorders, including symptoms that present primarily as poor concentration.
Coeliac disease and other causes of malabsorption.
Chronic inflammation, autoimmune disease or persistent infection where clinically indicated.
Perimenopause, particularly when sleep, cycle, vasomotor and mood symptoms occur together.
Medication effects, alcohol use, overtraining and inadequate energy intake.

A realistic investigation is prioritised, not indiscriminate. When energy and budget are limited, one or two well-chosen markers linked to the clinical question can provide more useful information than a comprehensive panel ordered without a clear rationale.

A practical order of investigation

Clarify the pattern. Record onset, fluctuations, sleep, menstrual or menopausal symptoms, diet, medication, alcohol, infections and neurological symptoms.
Start with high-yield basics. Consider full blood count, ferritin and iron studies, thyroid assessment, B12-related markers and glucose regulation according to history.
Add targeted tests. Consider vitamin D, magnesium, coeliac screening, inflammatory markers, sex hormones or further metabolic markers where the presentation supports them.
Correct identified deficiencies properly. Confirm the likely cause, use appropriate treatment and reassess rather than adding multiple supplements simultaneously.
Protect sleep first. The highest-yield modification for many people is consistent sleep timing and sufficient duration. Reduce alcohol, build protein and glucose stability into breakfast, and change one variable at a time.
Escalate when necessary. Persistent symptoms may require sleep assessment, psychological support, neurological assessment or review of medications.

Formula Health provides a 90-minute initial consultation and 60-minute follow-ups, supported by a joined-up multidisciplinary team: your health pitstop crew. The practice was founded by Gemma Fisher, the first Human Performance Consultant Osteopath in Formula 1, bringing elite-performance insight to personalised healthcare. Explore the Formula Health services.

When brain fog requires prompt assessment

Brain fog can occasionally be an early sign of a condition requiring urgent investigation. Seek prompt medical attention for rapidly progressive cognitive change, acute confusion, new weakness, facial drooping, speech disturbance, severe headache, seizure, loss of balance or other neurological findings.

References

Denno A, Hampshire A. Defining Brain Fog: A Transdiagnostic Narrative Review. European Psychiatry. 2025.
Systematic review and meta-analysis of long COVID mental health conditions and brain fog.
Nutritional approaches to brain fog, neuroinflammation, the gut-brain axis and sleep. Current Nutrition Reports. 2026.
Iron deficiency without anaemia: indications for treatment.
Active B12, homocysteine and functional B12 assessment.
Thyroid testing and the limitations of TSH alone.
American Thyroid Association guidance and thyroid testing principles. American Thyroid Association.
Fasting insulin and HOMA-IR in early metabolic risk.
Vitamin D thresholds and energy function.
Normal serum magnesium and potential limitations of blood testing.
Gurvich C, et al. Cognitive symptoms during menopause. The Lancet.
Maki PM, Jaff NG. Brain fog in menopause: an IMS White Paper. Climacteric. 2022.
Furey RT, Thomas EHX, Kulkarni J, Gurvich C. Subjective versus objective cognition during menopause: a systematic review and meta-analysis. Journal of the International Neuropsychological Society. 2025.
Whittaker AL, et al. A systematic review and meta-analysis of cognitive impairment following chemotherapy in breast cancer. Scientific Reports. 2022.
Homocysteine: the marker behind fatigue, brain fog and heart risk

Continue reading

Medical disclaimer: This article is for general information and does not replace an individual medical assessment, diagnosis or treatment plan. Test selection and interpretation should be based on your symptoms, history, examination and existing results. Seek urgent medical attention for acute confusion, rapidly progressive cognitive change or neurological symptoms.